Europe Wakes Up: The Coming Alliance Boom
Mid-size European drug companies have always been reluctant suitors when it comes to doing deals with US biotech companies. But judging by attendance at this year's Euro-Biotech Forum, they've gotten religion. Late-stage deal-making, still favored, is down, while more companies are willing to do research-stage deals.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.